The financial statements of dsm-firmenich include both the Consolidated Financial Statements and the Parent Company Financial Statements.
The Group’s parent company, DSM-Firmenich AG, is domiciled in Kaiseraugst (Switzerland) and listed on the Euronext Amsterdam stock exchange. The following Consolidated Financial Statements comprise DSM-Firmenich AG and its subsidiaries (the ‘Group’) and are prepared in accordance with IFRS. See also Note 1 General Information.
A list of the Group’s main participations can be found in Note 3 Investments to the Parent Company Financial Statements. The financial year 2024 covers the period from 1 January 2024 to 31 December 2024. The Board of Directors of DSM-Firmenich AG approved these statements for issue on 27 February 2025 and they are subject to the approval of the Annual General Meeting on 6 May 2025.
The accompanying notes are an integral part of these Consolidated Financial Statements.
See Note 2 Alternative performance measures for the reconciliation to Adjusted EBITDA of €2,118 million (2023: €1,443 million) and other non-IFRS performance measures.